-+ 0.00%
-+ 0.00%
-+ 0.00%

TREX BIO, INC- INTENDS TO USE ABOUT $90 MLN OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF TRB-061, INCLUDING TO FUND PHASE 2 TRIALS

Reuters·10/05/2026 10:37:11